drugset / Trial / NCT00003588
Gene Therapy in Treating Patients With Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase I trial to study the effectiveness of gene therapy in treating patients with ovarian cancer that has not responded to previous treatment. Inserting the p53 gene into a person's cancer cells may improve the body's ability to fight cancer or make the cancer cells more sensitive to treatment.
Timeline
- Start
- 1998-09
- Primary completion
- 2002-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CONTUSUGENE LADENOVEC | Unknown | — | Intrathecal |